Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Anthony Rosenberg?

Anthony Rosenberg

Managing Director

MPM Capital L.P.

HQ Phone:  (617) 425-9200

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

MPM Capital L.P.

450 Kendall Street

Cambridge, Massachusetts,02142

United States

Company Description

About MPM -- MPM Capital (www.mpmcapital.com) is an early-stage life sciences venture investing firm with a track record of identifying and building world-class companies around transformational treatments and cures. With its deep experience, dedicated team of... more.

Find other employees at this company (100)

Background Information

Employment History

Global Head, M&A and Licensing ( Corporate

Novartis AG


Head of Global Business Development and Licensing

Novartis AG


Affiliations

Idenix Pharmaceuticals , Inc.

Board Member


Radius Health, Inc.

Board Member


TriNetX Inc

Board Member


BioExec Institute

Board Member


Clinical Ink

Board Member


Strategy Committee

Board Member


Serodus ASA

Advisor


Pharma

Member of the Executive Committee


Novirio Pharmaceuticals , Inc.

Board Member


Technology Vision Group LLC

Advisory Board Member


Executive Committee Novartis Pharma AG

Head Partnering and Emerging Businesses, Member


PEC

Member


Education

Bachelor of Science degree

Biological Sciences

University of Leicester


Masters of Science

Physiology

University of London


Web References(100 Total References)


Anthony Rosenberg

www.bioexecinstitute.com [cached]

You are here: Home/Board of Directors/ Anthony Rosenberg
Anthony Rosenberg Managing Director, MPM Capital Anthony Rosenberg Prior to joining MPM, Tony served as Global Head, M&A and Licensing (Corporate) for Novartis, based in Basel, Switzerland. In this role Tony oversaw the Novartis portfolio transformation, a comprehensive set of transactions announced in 2014 to focus Novartis on its global businesses in innovative pharmaceuticals, eye care and generics. Tony is a Board member at Radius and a former board member at Idenix, both MPM portfolio companies. Tony joined Novartis predecessor company Sandoz in the U.K. in 1980, where he held diverse leadership positions across sales and marketing, business development and strategic planning. He moved to Basel in 1994, assuming roles of increasing responsibility, and in 2000 was appointed Global Head of the Transplantation and Immunology Business Unit. In 2005, Tony was appointed Global Head of Business Development and Licensing (Pharma), and managed over 30 major in-licensing transactions across therapeutic areas as well as numerous divestments. In 2010, he assumed added responsibility leading the Molecular Diagnostics Group. Tony has a Bachelor of Science degree in Biological Sciences from the University of Leicester and a Masters of Science in Physiology from the University of London.


trinetx.com

Tony Rosenberg
Tony Rosenberg Board Member Tony Rosenberg joined MPM in 2015. Prior to joining MPM, Tony served as Global Head, M&A and Licensing (Corporate) for Novartis (NVS), based in Basel, Switzerland. In this role Tony oversaw the Novartis portfolio transformation, a comprehensive set of transactions announced in 2014 to focus Novartis on its global businesses in innovative pharmaceuticals, eye care and generics. Tony is a Board member at Clinical Ink, Radius and TriNetX and is a former board member at Idenix, all MPM portfolio companies. Tony joined Novartis predecessor company Sandoz in the U.K. in 1980, where he held diverse leadership positions across sales and marketing, business development and strategic planning. He moved to Basel in 1994, assuming roles of increasing responsibility, and in 2000 was appointed Global Head of the Transplantation and Immunology Business Unit. In 2005, Tony was appointed Global Head of Business Development and Licensing (Pharma), and managed over 30 major in-licensing transactions across therapeutic areas as well as numerous divestments. In 2010, he assumed added responsibility leading the Molecular Diagnostics Group. Tony has a Bachelor of Science degree in Biological Sciences from the University of Leicester and a Masters of Science in Physiology from the University of London.


Anthony Rosenberg

www.bioexecinstitute.com [cached]

You are here: Home/Board of Directors/ Anthony Rosenberg
Anthony Rosenberg Managing Director, MPM Capital Anthony Rosenberg Prior to joining MPM, Tony served as Global Head, M&A and Licensing (Corporate) for Novartis, based in Basel, Switzerland. In this role Tony oversaw the Novartis portfolio transformation, a comprehensive set of transactions announced in 2014 to focus Novartis on its global businesses in innovative pharmaceuticals, eye care and generics. Tony is a Board member at Radius and a former board member at Idenix, both MPM portfolio companies. Tony joined Novartis predecessor company Sandoz in the U.K. in 1980, where he held diverse leadership positions across sales and marketing, business development and strategic planning. He moved to Basel in 1994, assuming roles of increasing responsibility, and in 2000 was appointed Global Head of the Transplantation and Immunology Business Unit. In 2005, Tony was appointed Global Head of Business Development and Licensing (Pharma), and managed over 30 major in-licensing transactions across therapeutic areas as well as numerous divestments. In 2010, he assumed added responsibility leading the Molecular Diagnostics Group. Tony has a Bachelor of Science degree in Biological Sciences from the University of Leicester and a Masters of Science in Physiology from the University of London.


Board of Directors

www.bioexecinstitute.com [cached]

Anthony Rosenberg
Anthony Rosenberg Managing Director, MPM Capital


16th Annual Biotech in Europe Investor Forum - SachsForum

www.sachsforum.com [cached]

Tony Rosenberg, Managing Director, MPM Capital LP


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory